✦ LIBER ✦

Immunogenicity of Infliximab in Crohn's Disease

Book ID: 118273988
Publisher: Massachusetts Medical Society
Year: 2003
Tongue: English
Weight: 66 KB
Volume: 348
Category: Article
ISSN: 0096-6762
DOI: 10.1056/nejm200305223482121

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Influence of Immunogenicity on the Long-

Influence of Immunogenicity on the Long-Term Efficacy of Infliximab in Crohn's Disease

✍ Baert, Filip; Noman, Maja; Vermeire, Severine; Van Assche, Gert; D' Haens, Geert 📂 Article 📅 2003 🏛 Massachusetts Medical Society 🌐 English ⚖ 103 KB

Influence of immunogenicity on the long-

Influence of immunogenicity on the long-term efficacy of infliximab in Crohn’s disease

✍ Chinyu G Su; Gary R Lichtenstein 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 61 KB

Tu1236 Comparison of Techniques for Moni

Tu1236 Comparison of Techniques for Monitoring Infliximab Bioavailability and Immunogenicity in Crohn's Disease

✍ Steenholdt, Casper; Svenson, Morten; Ainsworth, Mark A.; Thomsen, Ole.; Brynskov 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 183 KB

Incidence and clinical significance of i

Incidence and clinical significance of immunogenicity to infliximab in Crohn's disease: A critical systematic review

✍ Andrea Cassinotti; Simon Travis 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 167 KB

Background: Infliximab (IFX) is a chimeric (mouse/human) anti-TNF-alpha monoclonal antibody approved for the treatment of refractory luminal and fistulizing Crohn's disease (CD). It is a source of potential immunogenicity for humans, with the occurrence of anti-infliximab antibodies (ATIs), which ar

Treatment of Crohn's disease patients wi

Treatment of Crohn's disease patients with infliximab is detrimental for the survival of Mycobacterium avium ssp. paratuberculosis within macrophages and shows a remarkable decrease in the immunogenicity of mycobacterial proteins

✍ Horacio Bach; Greg Rosenfeld; Brian Bressler 📂 Article 📅 2012 🏛 Oxford University Press 🌐 English ⚖ 273 KB

Infliximab in Fistulizing Crohn's Diseas

Infliximab in Fistulizing Crohn's Disease

✍ Osterman, Mark T.; Lichtenstein, Gary R. 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 225 KB